Latest news
Adding Ibrutinib to Liso-Cel Drives Deep Remissions in R/R CLL/SLL - Targeted OncologyTargeted Oncology · Mon, 10 Aug 2026 16:07:16 GMTKyverna Therapeutics and ElevateBio Sign Commercial Manufacturing Agreement for Miv-Cel - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 14:47:53 GMT